A detailed history of Cutler Group LP transactions in Pfizer Inc stock. As of the latest transaction made, Cutler Group LP holds 10,075 shares of PFE stock, worth $253,184. This represents 0.09% of its overall portfolio holdings.

Number of Shares
10,075
Previous 131,012 92.31%
Holding current value
$253,184
Previous $3.77 Million 92.6%
% of portfolio
0.09%
Previous 0.34%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$25.89 - $29.73 $3.13 Million - $3.6 Million
-120,937 Reduced 92.31%
10,075 $279,000
Q4 2023

Jan 18, 2024

BUY
$26.13 - $33.94 $1.03 Million - $1.34 Million
39,367 Added 42.96%
131,012 $3.77 Million
Q3 2023

Nov 07, 2023

BUY
$32.09 - $37.51 $1.13 Million - $1.32 Million
35,198 Added 62.36%
91,645 $3.04 Million
Q2 2023

Jul 18, 2023

BUY
$36.12 - $41.79 $1.25 Million - $1.44 Million
34,537 Added 157.63%
56,447 $2.07 Million
Q1 2023

May 01, 2023

SELL
$39.39 - $51.28 $727,218 - $946,731
-18,462 Reduced 45.73%
21,910 $893,000
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $845,980 - $1.1 Million
-20,263 Reduced 33.42%
40,372 $2.07 Million
Q3 2022

Oct 25, 2022

BUY
$43.76 - $53.42 $958,869 - $1.17 Million
21,912 Added 56.59%
60,635 $2.65 Million
Q2 2022

Aug 04, 2022

SELL
$46.53 - $55.17 $7.91 Million - $9.38 Million
-170,002 Reduced 81.45%
38,723 $2.03 Million
Q1 2022

Apr 14, 2022

BUY
$45.75 - $56.69 $8.12 Million - $10.1 Million
177,548 Added 569.48%
208,725 $10.8 Million
Q4 2021

Jan 18, 2022

SELL
$41.32 - $61.25 $4.31 Million - $6.39 Million
-104,257 Reduced 76.98%
31,177 $1.84 Million
Q3 2021

Oct 26, 2021

BUY
$39.25 - $50.42 $4.69 Million - $6.03 Million
119,511 Added 750.56%
135,434 $5.83 Million
Q2 2021

Jul 19, 2021

SELL
$35.91 - $40.68 $660,384 - $748,105
-18,390 Reduced 53.59%
15,923 $623,000
Q1 2021

Apr 26, 2021

SELL
$33.49 - $37.77 $1.13 Million - $1.27 Million
-33,600 Reduced 49.48%
34,313 $1.24 Million
Q4 2020

Jan 21, 2021

SELL
$33.47 - $42.56 $1.02 Million - $1.3 Million
-30,476 Reduced 30.98%
67,913 $2.5 Million
Q3 2020

Oct 27, 2020

BUY
$31.75 - $37.25 $197,516 - $231,732
6,221 Added 6.75%
98,389 $3.61 Million
Q2 2020

Jul 22, 2020

SELL
$30.12 - $36.54 $52,107 - $63,214
-1,730 Reduced 1.84%
92,168 $3.01 Million
Q1 2020

May 07, 2020

BUY
$27.03 - $38.62 $1.75 Million - $2.5 Million
64,650 Added 221.04%
93,898 $3.06 Million
Q4 2019

Feb 06, 2020

BUY
$32.92 - $37.36 $820,267 - $930,899
24,917 Added 575.32%
29,248 $1.15 Million
Q3 2019

Oct 28, 2019

BUY
$32.49 - $42.13 $48,670 - $63,110
1,498 Added 52.88%
4,331 $155,000
Q2 2019

Aug 09, 2019

BUY
$36.98 - $41.52 $75,180 - $84,410
2,033 Added 254.12%
2,833 $122,000
Q1 2019

May 10, 2019

SELL
$37.5 - $41.2 $601,312 - $660,642
-16,035 Reduced 95.25%
800 $33,000
Q4 2018

Feb 05, 2019

SELL
$38.47 - $43.86 $176,962 - $201,756
-4,600 Reduced 21.46%
16,835 $734,000
Q3 2018

Nov 07, 2018

SELL
$34.47 - $41.81 $86,175 - $104,525
-2,500 Reduced 10.44%
21,435 $944,000
Q1 2018

May 11, 2018

SELL
$31.91 - $37.02 $60,629 - $70,338
-1,900 Reduced 7.35%
23,935 $849,000
Q4 2017

Jan 17, 2018

BUY
$33.26 - $35.29 $46,564 - $49,406
1,400 Added 5.73%
25,835 $935,000
Q3 2017

Oct 17, 2017

BUY
$31.0 - $34.15 $757,485 - $834,455
24,435
24,435 $872,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.